Benefit of Latanoprostene Bunod (Vyzulta) for Glaucoma Switched from Prior Pharmacotherapy: A Retrospective Cohort Study in Taiwan

Abstract Introduction Topical prostaglandin analogs (PGAs) are used to treat glaucoma and provide significant reductions in intraocular pressure (IOP). This study evaluated the efficacy and safety of latanoprostene bunod 0.024% (LBN; Vyzulta®) in Taiwanese patients with glaucoma who were switched fr...

Ausführliche Beschreibung

Bibliografische Detailangaben

Hauptverfasser:	Chen-Jui Chiu, Ying-Ying Chen, Yi-Shan Chen
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	Adis, Springer Healthcare 2026-04-01
Schriftenreihe:	Ophthalmology and Therapy
Schlagworte:	Latanoprostene bunod (LBN) Vyzulta Glaucoma Intraocular pressure (IOP) Prostaglandin (PG)
Online-Zugang:	https://doi.org/10.1007/s40123-026-01367-4
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!